[More care for a limited budget; a case for a better use of the efficiency criteria]
- PMID: 12481524
[More care for a limited budget; a case for a better use of the efficiency criteria]
Abstract
A systematic consideration of the cost-effectiveness in decisions concerning the financing and implementation of healthcare technologies would contribute to the efficiency of the Dutch healthcare system. This consideration applies to the initial decision to finance a project, the periodic testing of this on the basis of practice data and the policy to promote a cost-effective approach in daily practice (via practice guidelines). Bearing in mind that the government has decided to allocate few additional resources to healthcare, it should undertake measures to ensure the systematic use of such information in these steps. The National Institute for Clinical Excellence (NICE) in the United Kingdom can serve as an example, where broadly supported guidelines are drawn up with systematic attention for the cost-effectiveness and the implications for healthcare. Within this context the question arises as to whether a Dutch variant of NICE is needed.
Comment in
-
[More care for a limited budget; a case for a better use of the efficiency criteria].Ned Tijdschr Geneeskd. 2003 Jan 18;147(3):134; author reply. Ned Tijdschr Geneeskd. 2003. PMID: 12577774 Dutch. No abstract available.
-
[More care for a limited budget; a case for a better use of the efficiency criteria].Ned Tijdschr Geneeskd. 2003 Feb 22;147(8):363-4. Ned Tijdschr Geneeskd. 2003. PMID: 12661124 Dutch. No abstract available.
Similar articles
-
Procedures and methods of benefit assessments for medicines in Germany.Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5. Eur J Health Econ. 2008. PMID: 18987905
-
[Procedures and methods of benefit assessments for medicines in Germany].Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. Dtsch Med Wochenschr. 2008. PMID: 19034813 German.
-
How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.J Health Serv Res Policy. 2007 Apr;12(2):73-9. doi: 10.1258/135581907780279521. J Health Serv Res Policy. 2007. PMID: 17407655
-
Role of health technology assessment in shaping the benefits package in The Netherlands.Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):85-94. doi: 10.1586/14737167.9.1.85. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19371181 Review.
-
Assessment and regulation of health care technology. The Dutch experience.Int J Technol Assess Health Care. 1999 Fall;15(4):638-48. Int J Technol Assess Health Care. 1999. PMID: 10645105 Review.